Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Liver Cirrhosis

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    September 2025
  1. HASEGAWA Y, Obara H, Ojiro K, Kitago M, et al
    Trends and Barriers in Liver Transplantation for Patients With Decompensated Cirrhosis: A 15-Year Single-Center Cohort at a Japanese Center.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00453.
    PubMed     Abstract available


  2. EGELI T, Unek T, Ozbilgin M, Agalar C, et al
    Evaluation of Etiology Based on Post-Transplant Pathological Diagnosis in Cases of Cryptogenic Cirrhosis.
    Transplant Proc. 2025 Sep 16:S0041-1345(25)00384.
    PubMed     Abstract available


    September 2024
  3. RADOVITCH H, Le Sagere S, Cabarrou B, Maulat C, et al
    Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List.
    Transplant Proc. 2024 Sep 5:S0041-1345(24)00468.
    PubMed     Abstract available


    August 2024
  4. ANILIR E
    Evaluation of Factors Affecting Rehospitalization and Survival After Living Donor Liver Transplantation.
    Transplant Proc. 2024 Aug 26:S0041-1345(24)00434.
    PubMed     Abstract available


  5. AHMED H, Atiq M, Salih M, Bhatti AB, et al
    Impact of Sarcopenia on Post-Liver Transplant Hospitalization: Insights From a South Asian Cohort.
    Transplant Proc. 2024 Aug 24:S0041-1345(24)00445.
    PubMed     Abstract available


    July 2024
  6. THULUVATH AJ, Kim M, Peipert J, Duarte-Rojo A, et al
    Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis.
    Transplant Proc. 2024 Jul 17:S0041-1345(24)00326.
    PubMed     Abstract available


    May 2024
  7. GUO Y, Li S, Zhu Z, Cai W, et al
    Liver Transplantation for Diffuse Form of Caroli Disease with Chronic Hepatitis B: A Case Report.
    Transplant Proc. 2024 May 29:S0041-1345(24)00274.
    PubMed     Abstract available


    April 2024
  8. KANG SW, Ban JY, Park MS
    Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury (C57bl/6 Mouse).
    Transplant Proc. 2024;56:672-677.
    PubMed     Abstract available


  9. KANG HG, Park H, Myong GE, Kim WJ, et al
    Beneficial Effect of Rapamycin on Liver Fibrosis in a Mouse Model (C57bl/6 Mouse).
    Transplant Proc. 2024;56:701-704.
    PubMed     Abstract available


    February 2024
  10. UENO T, Takase K, Deguchi K, Nomura M, et al
    Clinical Implications of Serum Mac-2 Binding Protein in Patients After Living Donor Liver Transplantation for Biliary Atresia.
    Transplant Proc. 2024 Feb 14:S0041-1345(24)00006.
    PubMed     Abstract available


    September 2023
  11. BEZINOVER D, Alhkouri N, Schumann R, Geyer N, et al
    Liver Transplant Outcomes in Young Adults with Cirrhosis Related to Nonalcoholic Fatty Liver Disease.
    Transplant Proc. 2023 Sep 24:S0041-1345(23)00561.
    PubMed     Abstract available


    July 2023
  12. ALBAYRAK B, Ozcan H, Aksungur N, Cankaya E, et al
    Depression and Anxiety Symptoms in Patients With Cirrhosis: A Prospective Study Before and After Liver Transplantation.
    Transplant Proc. 2023 Jul 1:S0041-1345(23)00408.
    PubMed     Abstract available


    April 2023
  13. YAMANA H, Tokodai K, Fujio A, Kashiwadate T, et al
    Clinical Significance of the Mac-2 Binding Protein Glycosylated Isomer as a Surrogate Marker of Graft Fibrosis After Pediatric Liver Transplantation.
    Transplant Proc. 2023 Apr 30:S0041-1345(23)00227.
    PubMed     Abstract available


  14. ANILIR E, Oral A, Atasoy A, Civan HA, et al
    A Single-Center's Early Surgical Outcomes of Living Donor Liver Transplantation.
    Transplant Proc. 2023 Apr 28:S0041-1345(23)00156.
    PubMed     Abstract available


  15. YANAGAKI M, Onda S, Furukawa K, Taniai T, et al
    Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of <20.
    Transplant Proc. 2023 Apr 22:S0041-1345(23)00216.
    PubMed     Abstract available


  16. TAKASE K, Ueno T, Matsuki K, Todo M, et al
    Liver-Spleen Volume Ratio as a Predictor of Native Liver Survival in Patients with Biliary Atresia.
    Transplant Proc. 2023 Apr 20:S0041-1345(23)00135.
    PubMed     Abstract available


    March 2023
  17. ISHII M, Ibuki S, Morinaga J, Shimata K, et al
    Elevated Alfa-Fetoprotein and Des-Gamma-Carboxy Prothrombin Levels Predict Poor Outcomes After Liver Transplantation for Hepatocellular Carcinoma Beyond the Japan Criteria.
    Transplant Proc. 2023 Mar 31:S0041-1345(23)00118.
    PubMed     Abstract available


  18. VERMA S, Naganathan SK, Das LK, Agarwal S, et al
    Living Donor Liver Transplantation Alone Is Not Inferior to Combined Kidney Liver Transplant for Cirrhotic Patients With Chronic Kidney Disease.
    Transplant Proc. 2023 Mar 5:S0041-1345(23)00031.
    PubMed     Abstract available


  19. KUS AA, Yildiz I
    Is it Possible to Avoid Liver Biopsy in Living Donors for Liver Transplantation by Using Two-Dimensional Shear Wave Elastography?
    Transplant Proc. 2023 Mar 4:S0041-1345(23)00017.
    PubMed     Abstract available


  20. GRIFFETH EM, Burchill LJ, Dearani JA, Oberoi M, et al
    Optimizing Referral Timing of Patients With Fontan Circulatory Failure for Heart Transplant.
    Transplant Proc. 2023 Mar 1:S0041-1345(23)00041.
    PubMed     Abstract available


    January 2023
  21. BURGOS MM, Grande RG, Ortega SL, Leiva IS, et al
    Impact of HCV Treatment on Recurrence of Hepatocarcinoma After Liver Transplantation.
    Transplant Proc. 2023 Jan 25:S0041-1345(22)00884.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.